Exelixis
EXEL
#1758
Rank
โ‚น1.020 T
Marketcap
โ‚น3,792
Share price
-4.94%
Change (1 day)
27.36%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: โ‚น4,429 INR on 2000-07-26

Lowest end of day price: โ‚น116.01 INR on 2014-12-24

Stock price history of Exelixis from 2000 to 2025

Annual Stock Price Performance

Year Performance
2025 24.25%
2024 39.16%
2023 47.18%
2022-16.37%
2021-10.96%
2020 13.65%
2019-11.59%
2018-37.36%
2017 106.38%
2016 171.58%
2015 241.82%
2014-76.70%
2013 26.92%
2012-1.93%
2011-44.24%
2010 9.47%
2009 41.19%
2008-42.56%
2007-8.87%
2006-7.60%
2005 2.39%
2004 35.71%
2003-7.24%
2002-49.40%
2001 31.00%
2000-0.85%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
โ‚น4,359 0.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น4,356-2.20%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น8,897-0.79%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4,647-0.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น28,889-2.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น18,132-0.15%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น2,318-1.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น121.41 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,349 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA